Works from the first dose without needing liver activation
Effect does not vary with inherited enzyme differences
Manufactured at a WHO-GMP certified facility under GLP and ISO norms
Every batch quality tested in-house before dispatch
Indications of Glorinta-90
Acute coronary syndrome
After stent placement
After a heart attack
How Glorinta-90 works
Ticagrelor blocks the P2Y12 receptor like clopidogrel, but it binds reversibly and does not need to be activated by the liver first. So it starts working faster, its effect does not depend on which version of the CYP2C19 enzyme a patient inherited, and platelet function returns sooner once it is stopped.
Why ChooseGlorinta-90?
Manufactured at a WHO-GMP certified facility under GLP, ISO and GMP norms, with raw material from approved vendors and in-house quality testing on every batch. Cardiac medicines are taken every day for years, so batch-to-batch consistency is not a formality here -- it is what keeps a stable patient stable. Offered to PCD franchise partners on district-wise monopoly rights, with pan-India supply and complete promotional support.
Frequently asked questions about Glorinta-90
Is monopoly available for this product?
Yes. District-wise monopoly rights are offered across India. Tell us your district and we will confirm availability.
What is the composition of Glorinta-90?
Ticagrelor 90 mg.
Is this manufactured at a WHO-GMP certified facility?
Yes. Manufacturing follows GLP, WHO, ISO and GMP norms, and every batch is quality tested in-house before dispatch.
What is the minimum order quantity?
Please contact our team for the current MOQ and price structure for your territory.
Last updated on 29 August 2026
This information is for reference only and is not a substitute for advice from a qualified doctor or pharmacist. Please consult your physician before use.
Cista Medicorp